Sunday, April 28, 2024 1:24:57 PM
For now and 10% market share is pretty nice given the horrid launch. This share can and likely will increase with time given Daxxify is the best neurotoxin on the market.
Recent RVNC News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/10/2025 09:52:46 PM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 4, 2025 in Revance Lawsuit - RVNC • PR Newswire (US) • 01/09/2025 10:45:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/06/2025 02:00:47 PM
- Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics for $3.60 per Share in Cash • PR Newswire (US) • 01/06/2025 02:00:00 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 01/02/2025 09:45:08 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 01/02/2025 09:36:33 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/19/2024 02:00:18 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 12/12/2024 01:01:36 PM
- Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per share • PR Newswire (US) • 12/12/2024 01:00:00 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 12/12/2024 12:15:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2024 11:01:00 AM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 12/09/2024 10:16:28 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 12/09/2024 02:24:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 02:17:44 PM
- Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement • PR Newswire (US) • 12/09/2024 01:30:00 PM
- Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement • Business Wire • 12/09/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2024 09:23:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 01:27:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 11:02:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2024 11:01:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 09:31:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 09:01:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:12:12 PM
- Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 11/07/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 01:24:24 PM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM